01CHEMISTRY
Detect with precision.
Build around high-quality detection chemistry designed to capture meaningful biomarker information reliably.
Redefining Access to Quantitative Diagnostics
Quantiva DX is developing a new approach to point-of-care diagnostics—one designed to make quantitative biomarker information faster, simpler and more accessible.
Development-stage diagnostic technology
A result can be fast.
A result can be informative.
We
believe it should
be both.
We believe it should
01 / SPEED
Move with the moment.
Diagnostic information is most useful when it arrives in time to influence the next decision.
02 / INFORMATION
Preserve what matters.
Speed should not mean reducing important biomarker information to a simple binary answer.
03 / ACCESS
Reduce the infrastructure.
We are designing compact formats that reduce reliance on complex laboratory systems and dedicated instrumentation.
Quantitative testing can be powerful. The systems around it can be demanding.
Important biomarker information is often tied to instrumentation, laboratory infrastructure, specialized workflows and time. Quantiva DX is exploring what changes when more of that complexity can be designed out.
InstrumentationDedicated analyzers can shape where testing can happen.
InfrastructureConventional workflows can require more space, systems and
support.
WorkflowMore steps can increase the distance between sample and
information.
AccessComplexity can limit how close meaningful measurement gets to
the point of care.
The Quantiva approach
Advanced detection.
Simpler delivery.
Our technology combines advanced detection chemistry with compact, intuitive test formats designed to reduce reliance on complex laboratory infrastructure and dedicated instrumentation.
02FORMAT
Make the system smaller.
Translate sophisticated detection into compact test formats engineered around practical point-of-care use.
03EXPERIENCE
Make the information clearer.
Design results to be intuitive—so important information is easier to access, understand and use when decisions are being made.
Drop a full-width visual here
Use a highly cinematic card detail, assay chemistry macro, material study or clinical environment.
Use a highly cinematic card detail, assay chemistry macro, material study or clinical environment.
Designed around the point of decision
Drop the CRP card render here
Transparent product render works especially well in this space.
Transparent product render works especially well in this space.
First development program
One biomarker.
A broader idea.
Our first development program focuses on C-reactive protein (CRP), translating an important inflammatory biomarker into a rapid, visual result using a compact card-based platform.
The CRP card is the first expression of the Quantiva DX philosophy: preserve meaningful information, simplify the system around it, and move that information closer to the point of care.
What we believe
Better diagnostic technology should do more than generate data. It should make meaningful information easier to use.
At Quantiva DX, that means making important biomarker information easier to access, easier to understand and available closer to the moment decisions are made.
Explore Quantiva DX
We are beginning with CRP. The idea is bigger than a single card.
Explore the development program behind our first product or learn more about the mission, thinking and technology direction shaping Quantiva DX.
Development-stage technology. Product design, specifications,
performance characteristics, regulatory status and commercial
configuration remain subject to development, validation and
applicable regulatory review.
Contact
Get in touch.
Questions about Quantiva DX or our development program? Send us a message and our team will get back to you.
- Address
- 3004 Park Central Ave
Nicholasville, KY 40356 - Phone
- 859-592-8525
- info@quantivadx.com